Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Journal of Proteome Research|September 11, 2007
Autoantibody signature in human ductal pancreatic adenocarcinomaBarbara Tomaino, Paola Cappello, Michela Capello, et al.Cancer Discovery|May 15, 2016
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma ProgressionMegan M Kaneda, Paola Cappello, Abraham V Nguyen, et al.Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functionsGianluca Mucciolo, Claudia Curcio, Cecilia Roux, et al.Journal of Hematology & Oncology|September 10, 2013
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse modelsMichela Capello, Paola Cappello, Federica Caterina Linty, et al.Proceedings of the National Academy of Sciences of the United States of America|February 17, 2019
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1Cecilia Roux, Soode Moghadas Jafari, Rahul Shinde, et al.Gut|November 12, 2018
Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancerDelphine Goehrig, Jérémy Nigri, Rémi Samain, et al.Clinical and Translational Medicine|August 20, 2025
The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinomaGiorgia Tiberi, Alessandro Scagliotti, Claudia Curcio, et al.Frontiers in Immunology|January 27, 2025
Loss of <i>Parp7</i> increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltrationVinicius Kannen, Marit Rasmussen, Siddhartha Das, et al.Molecular Cancer Therapeutics|September 23, 2021
Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and ResistanceCélia Cintas, Thibault Douche, Zahra Dantes, et al.Journal of Proteome Research|May 12, 2010
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancerBarbara Tomaino, Paola Cappello, Michela Capello, et al.Pageof 9